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Background: Research indicates 10-15% of patients with presumed ST-elevation myocardial infarction (STEMI) will not have a clear culprit artery. 
Accurate diagnosis in these patients is often challenging. We examined the value of cardiac MRI (CMR) in determining the etiologies and outcomes 
in patients with “no culprit” STEMI.
Methods: Data from a prospective registry of STEMI patients was queried from March 2003 to December 2009. CMR was performed at the 
discretion of the attending cardiologist.
Results: 412 (15%) of 2,728 consecutive Level 1 MI patients had no clear culprit artery. Of these, 201 (47.4%) had abnormal cardiac biomarkers 
with a definitive diagnosis in 157 (78%). In 210 patients with normal biomarkers, only 82 (39%) received a definitive diagnosis. (Table 1) CMR was 
performed in 123 (30%) of “no culprit” patients. Patients who received CMR were more likely to have a definitive diagnosis than those who did not 
(95[77%] vs. 144[50%], p=0.01). Specifically, patients with abnormal biomarkers and with CMR were more likely to have a definitive diagnosis than 
those with abnormal biomarkers and without CMR (78[91%] vs. 70[69%], p<0.001). CMR led to a diagnosis different from the presumptive clinical 
diagnosis 53% of the time.
Conclusions: “No culprit” STEMI patients with positive biomarkers have similar mortality to STEMI patients with a culprit artery. CMR is a valuable 
diagnostic tool to help determine accurate diagnosis and treatment.
